Gilead Sciences, Inc.
GILD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882095
In the last 90 days, Gilead Sciences, Inc. insiders filed 0 open-market purchases and 11 sales; 2,292 institutions reported holding it in 13F filings for Q2 2026, worth $140.5B in total; no superinvestor holds it.
Superinvestors holding GILD, Q2 2026
No superinvestor reported holding GILD in Q2 2026.